Welcome to our dedicated page for Locksley Res news (Ticker: LKYLY), a resource for investors and traders seeking the latest updates and insights on Locksley Res stock.
Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect Locksley Res's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.
Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of Locksley Res's position in the market.
Locksley Resources (ASX: LKY / ADR: LKYLY) completed an oversubscribed placement raising approximately A$17 million via new shares priced at A$0.24 per share to Australian, U.S. and international investors on Dec 8, 2025.
Cornerstone participation from established U.S. institutional investors was cited as a strategic endorsement of Locksley's U.S. "Mine to Market" critical minerals plan, which targets the Mojave Project (REE) and the Desert Antimony Mine and includes a collaboration with Rice University on DeepSolv™ for domestic antimony processing. Settlement is expected on or around Dec 11, 2025 and new shares will rank equally with existing ordinary shares.
FAQ
What is the current stock price of Locksley Res (LKYLY)?
